Ifp Advisors, Inc Aim Immuno Tech Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.91 - $2.17 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.93 - $2.39 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$1.88 - $2.82 $107 - $160	-57 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.68 - $2.45 $95 - $139	57 New	57 $0

9.04M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.